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Abstract
Objectives Develop predictive models for a paediatric
population that provide information for paediatricians
and health authorities to identify children at risk of
hospitalisation for conditions that may be impacted
through improved patient care.
Design Retrospective healthcare utilisation analysis with
multivariable logistic regression models.
Data Demographic information linked with utilisation
of health services in the years 2006–2014 was used to
predict risk of hospitalisation or death in 2015 using a
longitudinal administrative database of 527 458 children
aged 1–13 years residing in the Regione Emilia-Romagna
(RER), Italy, in 2014.
Outcome measures Models designed to predict risk
of hospitalisation or death in 2015 for problems that are
potentially avoidable were developed and evaluated using
the C-statistic, for calibration to assess performance
across levels of predicted risk, and in terms of their
sensitivity, specificity and positive predictive value.
Results Of the 527 458 children residing in RER in 2014,
6391 children (1.21%) were hospitalised for selected
conditions or died in 2015. 49 486 children (9.4%) of the
population were classified in the ‘At Higher Risk’ group
using a threshold of predicted risk >2.5%. The observed
risk of hospitalisation (5%) for the ‘At Higher Risk’
group was more than four times higher than the overall
population. We observed a C-statistic of 0.78 indicating
good model performance. The model was well calibrated
across categories of predicted risk.
Conclusions It is feasible to develop a population-based
model using a longitudinal administrative database
that identifies the risk of hospitalisation for a paediatric
population. The results of this model, along with profiles
of children identified as high risk, are being provided to
the paediatricians and other healthcare professionals
providing care to this population to aid in planning for
care management and interventions that may reduce
their patients’ likelihood of a preventable, high-cost
hospitalisation.

Introduction
Healthcare systems have been moving from a
passive approach of waiting for and reacting
to patients’ problems to a more active model

Strengths and limitations of this study
►► This study included the entire paediatric population

of the Emilia-Romagna Region of Italy, with a total of
527 458 children ages 1–13 years.
►► The study used an existing longitudinal administrative healthcare database with both the advantage of
much lower cost than new data collection and the
disadvantage of gaps and potential errors in administrative data.
►► The results of the study are being used to assist
paediatricians and health authorities manage highrisk children.

that includes identification of patients at
risk, taking the initiative in offering care
and actively seeking to avoid recurrence
or progression of medical problems. With
the ageing of populations worldwide, and
high prevalence of chronic diseases, it is
not surprising that these efforts have often
focused on the elderly. Less attention has
been paid to the paediatric population.
However, despite the relatively low prevalence of chronic disease in children, there is
evidence that children experience preventable hospitalisations.1 For example, a study
of paediatric inpatient claims in the USA estimated that paediatric ‘ambulatory care sensitive’ conditions accounted for US$4.05 billion
in hospital charges and over 1 million hospitalisation days in a 1-year period.2
Predictive risk modelling is a tool that can
be used to estimate the risk of an outcome
within the context of prespecified variables
and uncertainty. Predictive risk modelling
may offer an opportunity to better understand individuals who may be at higher risk
for an undesirable outcome.3 A number of
predictive risk modelling studies have been
conducted in paediatrics; however, many
of these studies have focused on children
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Methods
Data source
The RER is a region of northern Italy that lies between
the River Po and Apennine Mountains with approximately 4.5 million inhabitants. RER maintains a longitudinal healthcare database for all its residents. The RER
database contains patient-level demographic data (age,
gender, birth and death dates, location of residence and
primary care physician/paediatrician) and utilisation
data for inpatient (hospital discharge abstract data with
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) diagnosis and procedure codes and admission/discharge dates), outpatient
(laboratory, diagnoses and physician services, and pharmacy claims including WHO Anatomical Therapeutic
Chemical (ATC)/Defined Daily Dose (DDD) system
codes),12 specialty (therapeutic procedures, rehabilitation and specialist visits) and emergency room (ER)
visits. Inpatient medications are not captured. Patients
with disabilities or low family income are eligible for
exemption of service copayment for specialty visits and
2

outpatient prescriptions, which provide some socioeconomic information. Each resident is assigned an anonymous identifier so that utilisation can be tracked over
time while maintaining patient privacy.13
Study cohort
In Italy, children aged 14 years are required to switch
from a paediatrician to a primary care physician; therefore, we limited the study population to children 1–13
years old on 31 December 2014. The study population
also was narrowed to exclude children who did not reside
in RER for the entire year 2014. The study population
was stratified into three age groups: 1–2 years old (on 31
December 2014); 3–5 years old; and 6–13 years old. Children less than 1 year old on 31 December 2014 were not
included in the study population due to insufficient data
for prediction of outcomes.
Dependent variable
The outcome was defined as the occurrence of hospitalisation that could have potentially been prevented or
delayed with appropriate patient care or death by any
cause.11 We developed a list of hospitalisations that are
potentially preventable with appropriate patient care
using a three-step process. First, we conducted a literature
search to evaluate paediatric studies that defined potentially avoidable disease in paediatrics that could require
hospitalisation.14–16 We began with the listing of ICD-9-CM
codes for ‘pediatric ambulatory care sensitive conditions’
identified in Shi and Lu.15 All hospitalisations in 2013 of
children in the target age groups were classified using
both ICD-9-CM codes and Disease Staging categories.17 18
The results were reviewed by the authors of this paper and
compared with Shi et al’s list. A number of changes were
made for this project. For example, the list of immunisation preventable conditions to be included in the dependent variable was expanded to include currently available
vaccines. We included additional conditions, such as
acute cystitis (ICD-9-CM code of 595.0) and hypoglycaemic coma (ICD-9-CM code of 251.0). Advanced stages
of selected medical problems were added where stage one
may not be avoidable but advanced stages can potentially
be delayed or prevented through timely intervention, for
example, stage 2 or 3 appendicitis, stage 2 or 3 sinusitis.
While certainly not always preventable, we believed that
inclusion of hospitalisations for certain types of trauma
and toxicities (eg, acetaminophen toxicity, adverse drug
reactions and burns) was appropriate especially for a
paediatric population. These changes are summarised in
online supplementary appendix 1.
Finally, we used disease staging categories for inclusion
of relevant hospitalisations that would have been missed
using solely primary ICD-9-CM codes. For example, if a
child was hospitalised with a primary diagnosis of respiratory failure with asthma (ICD-9-CM code of 493) as
the secondary diagnosis, then the disease staging category of asthma would include that admission that might
have been missed by including only primary ICD-9-CM
Louis DZ, et al. BMJ Open 2018;8:e019454. doi:10.1136/bmjopen-2017-019454
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with specific medical problems or use data that are not
routinely available in administrative databases.4–9
Under the auspices of the Italian National Health Service
(NHS), the 21 regional governments are responsible for
delivering healthcare through a network of geographically
defined Local Health Authorities. Primary care physicians,
including paediatricians, work for the Local Health Authorities as independent contractors. Every Italian is expected
to enrol with a primary care physician (a paediatrician for
those under age 14 years) who serve as the ‘gatekeepers’ for
delivering primary care and coordinating specialty services
for their enrolled patients.10 This focus on primary care is
ideal for the development and implementation of a proactive model of healthcare.
To further encourage coordinated care, the Regione
Emilia-Romagna (RER) has established Patient-Centered Medical Homes. The identification of patients who
would most benefit from outreach efforts is fundamental
to achieving the goals of promoting population health
and practising proactive medicine. The RER has therefore developed and implemented a population-based
model to predict risk of hospitalisation or death for
adult residents in the region.11 The results of the model
are presented to physicians in Patient-Centered Medical
Homes as patient profiles to support care management
and the identification of patients who may benefit from
additional outreach such as home healthcare, disease
management or case management.
Current risk models used in RER focus on the adult
population. This paper describes the development of
predictive risk models for the paediatric population using
the RER’s regional longitudinal administrative healthcare
database to help identify children who are at risk of hospitalisation for conditions that may be affected through
improved patient care.

Open Access

Independent variables
A list of predictor variables was developed using the RER
administrative data from 2006 to 2014. Independent
variables included information such as: demographics,
socioeconomic factors, diseases/conditions grouped by
aetiology or body systems, mother’s medical history and
pregnancy/birthing information, ER visits, potentially
inappropriate prescriptions and antibiotic usage.
Demographic variables included age on 31 December
2014, gender and citizenship (Italian or non-Italian).
Children from low-income families or with disabilities are
exempt from copayments for prescriptions and specialty
visits. This information was used as a potential predictor
variable.
We mapped diseases defined primarily by the affected
body system with the exceptions of cancer, genetic conditions and trauma, which were based on aetiology11 using
2014 hospital discharge data, outpatient prescription
information and specialty visit claims. A total of 24 groups
were defined. Disease staging diagnostic categories was
used to map hospital admissions to the 24 body system/
aetiology groups17 (see first column of table 1). Patients
with cardiovascular diseases, chronic respiratory diseases,
diabetes mellitus, epilepsy and disorders of the thyroid
were identified using the ATC Classification System codes
from outpatient prescriptions.19 Specialty visit records
were also used for identifying medical conditions of
some body systems. For example, if a child was admitted
to the hospital for type 1 diabetes mellitus, or visited an
endocrinologist, or had filled a prescription for insulin
injection(s) (ATC code of A10AB), this patient would be
identified as having an endocrine diagnosis in 2014.
Severity level codes (critical (C), acute (A), urgent but
deferred (U) and not urgent (N)) are assigned to individuals on discharge from the emergency department. We
excluded ER visits that resulted in a hospital admission
because diagnosis information was captured by hospital
discharge data with more accurate information. We
believe more frequent or severe ER visits may indicate a
poor outcome; therefore, number of ER visits by severity
level was calculated for each patient.
There is evidence that the risks outweigh the benefits
for certain medication usage in the paediatric population.20 For example, certain mood-altering medications
such as, citalopram, sertraline, fluvoxamine and any tricyclic antidepressants are not recommended in children of
any age. Some medications can be harmful within specified ages. For example, loperamide is not indicated for
children under 3 years old. For children who filled an
outpatient prescription in 2014, we calculated their age
at dispensation date and amount of medications they
had filled, in order to identify patients with potentially
Louis DZ, et al. BMJ Open 2018;8:e019454. doi:10.1136/bmjopen-2017-019454

inappropriate prescriptions in 2014. The number of antibiotic prescriptions used in 2014 was estimated since high
utilisation of antibiotics has been linked to decreased gut
microflora, decreased immune function and resistant
strains of bacteria.21
For children ages 1–5 years, the models considered
problems identified at birth as potential predictors
using hospital discharge abstract data. About 86% of the
newborns were healthy, with no serious medical problems
noted on their birth records. Infants with diagnostic categories of premature birth with low birth weight, full-term
infants with abnormal birth weight, premature with very
low birth weight or extremely low birth weight, were classified as abnormal birth weight; all other conditions were
considered as a group. The mothers’ delivery information, such as age at delivery, C-section and parity, were
identified based on the mothers’ hospitalisation records
and linked to children. Information about deliveries that
occurred outside hospitals could not be captured.
Children ages 1–5 years old were also linked with information regarding their mothers’ medical history and drug
use during pregnancy. There is evidence on the association between prenatal (up to 270 days before delivery)
exposure to antibiotics and the development of asthma.22
We estimated the total exposure to any antibiotics
during the prenatal period using the mother outpatient
prescription claims. We included two categories of mother’s potentially inappropriate drug use, class D (potential risks outweigh the benefits) and X (contraindicated
during pregnancy), since these drugs may be linked to
harm to children. Mothers’ 3-year medical history before
delivery was retrieved for identifying certain conditions
such as abortion, diabetes and psychological condition.
For about 22% of children, we were not able to establish
the mother–baby linkage.
We developed history variables with up to 5 years of data
(pharmacy, specialty, hospital admission and ER visit) for
children in age strata 3–5 years old and 6–13 years old.
Children who had conditions in any year from 2009 to
2013 were flagged as having a utilisation history.
Modelling
Logistic regression was used to estimate predicted probabilities for the occurrence of an inpatient hospital stay for
the selected conditions, or death from any cause, for the
individual patients. Since age and gender may be strongly
correlated with children’s risk, we fit a total of six multivariable logistic regression models: female and male by
age groups (1–2, 3–5 and 6–13 years old). All models were
developed using SAS V.9.3 statistical software.
Model validation
The predicted accuracy of the modelling was evaluated using
C-statistics (the area under the receiver operating characteristics curve), comparing the results of the ‘predicted’
to the ‘observed’ outcomes in 2015. We stratified patients
into risk strata based on the predicted risk of hospitalisation or death. ‘At higher risk’ was defined as children with
3
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codes. This is summarised in online supplementary
appendix 2.
Children hospitalised for these selected conditions or
who died from any cause in 2015 were counted as being
positive for the outcome.
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At higher risk

Higher than average

Lower than average

Total population

Risk >2.5%

Risk >1.2%–2.5%

Risk ≤1.2%

527 458

49 486

99 714

378 258

Number

%

Number

%

Number

%

Number

%

Gender
  Female

255 875

48.5

20 315

41.1

43 030

43.2

192 530

50.9

  Male

271 583

51.5

29 171

58.9

56 684

56.8

185 728

49.1

  1–2

78 051

14.8

18 112

36.6

44 084

44.2

15 855

4.2

  3–5

125 459

23.8

20 180

40.8

35 543

35.6

69 736

18.4

  6–13

323 948

61.4

11 194

22.6

20 087

20.1

292 667

77.4

Age group (years)

Selected condition/body system
  Cancer

1138

0.2

477

1.0

252

0.3

409

0.1

  Cardiovascular

1624

0.3

653

1.3

211

0.2

760

0.2

442

0.1

138

0.3

109

0.1

195

0.1

  Dental conditions
  Endocrine

6458

1.2

1276

2.6

1074

1.1

4108

1.1

31 919

6.1

21 664

43.8

7376

7.4

2879

0.8

  Eye

821

0.2

165

0.3

145

0.1

511

0.1

  Genetic conditions

274

0.1

188

0.4

29

0.0

57

0.0

  Gastrointestinal

7380

1.4

2724

5.5

1578

1.6

3078

0.8

  Genitourinary

3389

0.6

987

2.0

836

0.8

1566

0.4

128

0.0

17

0.0

19

0.0

92

0.0

  Ear, nose, throat

  Obstetric and
gynaecologic conditions
  Haematological

1114

0.2

596

1.2

247

0.2

271

0.1

  Hepatobiliary

245

0.0

82

0.2

39

0.0

124

0.0

  Immunological disease

199

0.0

80

0.2

45

0.0

74

0.0

  Infectious disease

869

0.2

596

1.2

160

0.2

113

0.0

  Male genital

1329

0.3

179

0.4

209

0.2

941

0.2

  Musculoskeletal

3817

0.7

664

1.3

453

0.5

2700

0.7

  Neurological diseases

3738

0.7

2123

4.3

912

0.9

703

0.2

  Nutrition
  Other conditions
  Neonatal conditions
  Psychological

924

0.2

446

0.9

201

0.2

277

0.1

1703

0.3

1150

2.3

247

0.2

306

0.1

186

0.0

111

0.2

50

0.1

25

0.0

854

0.2

388

0.8

141

0.1

325

0.1

  Respiratory

20 450

3.9

7285

14.7

5886

5.9

7279

1.9

  Skin

39 344

7.5

5809

11.7

7461

7.5

26 074

6.9

737

0.1

177

0.4

167

0.2

393

0.1

  Trauma

Emergency room visits based on severity level
  Critical
  Acute
 Urgent but could be
deferred
  Not urgent
Inappropriate medication
prescriptions20
Antibiotic use
 1

182

0.0

117

0.2

35

0.0

30

0.0

15 029

2.8

5219

10.5

3915

3.9

5895

1.6

118 372

22.4

26 945

54.5

33 241

33.3

58 186

15.4

45 336

8.6

11 216

22.7

13 080

13.1

21 040

5.6

8077

1.5

2376

4.8

3090

3.1

2611

0.7

114 421

21.7

8248

16.7

24 544

24.6

81 629

21.6
Continued
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Table 1 Study population 2014
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Total population
527 458
Number

At higher risk

Higher than average

Lower than average

Risk >2.5%

Risk >1.2%–2.5%

Risk ≤1.2%

49 486
%

Number

99 714

378 258

%

Number

%

Number

%

 2

63 151

12.0

9359

18.9

19 035

19.1

34 757

9.2

 3+

76 878

14.6

25 587

51.7

29 144

29.2

22 147

5.9

Non-Italian citizen

90 760

17.2

8975

18.1

18 390

18.4

63 395

16.8

Copay exempted based on
family income/employment
status

244 911

46.4

37 502

75.8

64 776

65.0

142 633

37.7

Copay exempted based on
disabled status

6173

1.2

2029

4.1

1321

1.3

2823

0.7

12 642
8982

2.4
1.7

3987
2060

8.1
4.2

2735
2294

2.7
2.3

5920
4628

1.6
1.2

Specialty visits in paediatrics
  Medical
  Surgical

a predicted risk greater than 2.5%. ‘Higher than average’
was defined as children with a predicted risk of hospitalisation or death between the mean rate and 2.5%. The rest of
population was grouped into ‘Lower than average’. These
risk strata were defined to yield a manageable number of
patients to review for the typical paediatric panel of approximately 800 patients. Calibration of the model across
these risk groups was assessed by comparing observed to
predicted rates among the risk groups. We also report the
sensitivity, specificity and positive predictive value (PPV) for
the defined risk group cut-offs.
Results
Characterisation of risk groups
A total of 568 117 children ages 1–13 years resided in RER
in 2014. We excluded from our analysis 40 659 children
(7.2%) who did not reside in RER for the entire year,
resulting in a population of 527 458 children. Of those, 6391
children (1.21%) were hospitalised for selected conditions
or died in 2015. Table 1 displays the distribution of gender,
age category, presence of selected chronic conditions, ER
visits, selected prescription drug usage, copay exemption
for income or disability and specialty visits for the eligible
RER residents as of 31 December 2014.
Table 1 also compares the characteristics of the total
selected paediatric population to the subgroups of the
population classified by risk categories based on the
model results. Forty nine thousand four hundred and
eighty-six children (9.4%) of the population were classified in the ‘At higher risk’ group using a threshold of
predicted risk >2.5%. The children predicted to be 'At
higher risk' were more likely to be male (58.9%) compared
with 51.5% in the total population. The two youngest age
strata (1–2 and 3–5 years) had much higher proportions
of children identified in the 'At higher risk' group than
the children aged 6–13 years. For example, 18 112 (23%)
Louis DZ, et al. BMJ Open 2018;8:e019454. doi:10.1136/bmjopen-2017-019454

of the children age 1–2 years were identified in the 'At
higher risk' group. This age category includes 36% of
the 'At higher risk' children, although it represents 15%
of the total paediatric population. Children in the ‘At
higher risk’ category were more likely to have each of the
selected conditions. When looking at the highest prevalence conditions, 43.8% of children in the ‘At higher risk’
category had an ear, nose or throat problem, compared
with 6.1% in the overall population, 5.5% had a gastrointestinal problem compared with 1.4% in the overall population, 4.3% had a neurological problem compared with
0.7% in the overall population, 14.7% had a respiratory
problem compared with 3.9% in the overall population
and 11.7% had a skin problem compared with 7.5% in
the overall population.
Children identified as being ‘At higher risk’ were much
more likely to have a history of ER visits and were more
likely to have a history of 2, 3 or more antibiotic prescriptions. Overall, 14.6% of children had three or more antibiotic prescriptions, while in the ‘At higher risk’ category,
51.7% had a history of 3 or more antibiotic prescriptions.
Children with exemptions from copayments due to either
family income or disability were more likely to be identified as being 'At Higher Risk' as were children with a
history of medical or surgical specialty visits.
Table 2 displays information about the delivery (for
the children age 1–5 years) and medical history of the
mother for those children where we were able to match
to their mother’s record. First children, children who
were delivered by caesarean section and children where
an abnormal birth weight or other problems were noted
at birth were more likely to be classified in the ‘At higher
risk’ category. If the mother was prescribed a potentially
inappropriate drug or an antibiotic during pregnancy,
the child was more likely to be classified in the ‘At higher
risk’ category. When examining a 3-year medical history
5
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At higher risk

Higher than average

Total population

Risk >2.5%

Risk >1.2%–2.5%

Risk ≤1.2%

203 510

38 292

79 627

85 591

Number %

Number

%

Number

%

Lower than average

Number

%

Birthing
 Age at delivery (years)†
  24 and less

12 728

6.3

3275

8.6

5651

7.1

3802

4.4

   25–34

88 370

43.4

18 227

47.6

35 681

44.8

34 462

40.3

   35–39

45 575

22.4

8170

21.3

17 679

22.2

19 726

23.0

  40 and over

12 529

6.2

2344

6.1

4528

5.7

5657

6.6

 First delivery

99 190

48.7

23 336

60.9

42 662

53.6

33 192

38.8

 C-section

48 282

23.7

11 370

29.7

19 480

24.5

17 432

20.4

172 497

84.8

30 214

78.9

67 522

84.8

74 761

87.3

  Abnormal birth weight

20 128

9.9

4757

12.4

7756

9.7

7615

8.9

  Other abnormal birth
condition

10 885

5.3

3321

8.7

4349

5.5

3215

3.8

 Baby’s birth condition
   Normal newborns

Medical history
 Number of ordinary hospitalisation 1 year before delivery
   1

16 145

7.9

4578

12.0

6856

8.6

4711

5.5

3920

1.9

1670

4.4

1500

1.9

750

0.9

   2+

 Inappropriate prescription during pregnancy
   Class D

10 594

5.2

2970

7.8

3886

4.9

3738

4.4

   Class X

4874

2.4

1086

2.8

1811

2.3

1977

2.3

60 679

29.8

14 422

37.7

25 757

32.3

20 500

24.0

 Antibiotic use during
pregnancy

 3-year history before delivery
   Abortion

19 919

9.8

4970

13.0

8165

10.3

6784

7.9

   Asthma

35 590

17.5

9026

23.6

14 894

18.7

11 670

13.6

188

0.1

36

0.1

14

0.0

138

0.2

18 756

9.2

5068

13.2

7742

9.7

5946

6.9

   Bacterial pneumonia
   Cardiovascular disease

2602

1.3

1003

2.6

1106

1.4

493

0.6

   Hypertension

   Diabetes

140

0.1

51

0.1

39

0.0

50

0.1

   Infection
   Psychological
condition

935

0.5

283

0.7

325

0.4

327

0.4

9215

4.5

2701

7.1

3709

4.7

2805

3.3

*Information about the delivery was considered only for children 1–5 years old.
†For 22% of children, we were not able to establish the mother–baby linkage.

of the mother, the mother’s asthma, cardiovascular
disease, diabetes mellitus or mental health problems,
or the record of a previous abortion, were all relatively
frequent and more prevalent in the mothers of children
predicted to be in the ‘At higher risk’ category.
Calibration
The population was divided into three risk groups based on
predicted probability of hospitalisation as defined above.
We observed good calibration; each stratum’s predicted
risks were similar to observed prevalence of hospitalisations
6

or deaths (figure 1). Individuals, who fell in the ‘At higher
risk’ group, with predicted risk greater than 2.5%, had
2683 predicted events based on the model results, and 2737
observed events. While the overall rate of hospitalisation or
death for children ages 1–13 years was 1.21%, the predicted
and observed risk of the ‘At higher risk’ group was over 5%.
Model performance among risk groups
We observed a C-statistic of 0.78 indicating good model
performance (table 3). The sensitivity (proportion
Louis DZ, et al. BMJ Open 2018;8:e019454. doi:10.1136/bmjopen-2017-019454
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Model calibration: predicted and observed prevalence of hospitalisation or death in 2015 by risk category.

predicted to be at higher risk of those who had an event
in 2015) was 0.43 and 0.70 for predicted risk categories
of ‘At higher risk’ and ‘Higher than average’, respectively (table 4). In other words, among those whom were
hospitalised or deceased in 2015, 43% were predicted to
have risk greater than 2.5% of hospitalisation or death
and 70% have risk higher than average. The specificity
(proportion predicted to be at a ‘lower’ risk of those who
did not have an event) was 0.91 and 0.72 for the predicted
‘At higher’ and ‘Higher than average’ risk categories,
respectively; among those who were not hospitalised and
did not die in 2015, 91% were not predicted to be ‘At
higher risk’. The PPV (proportion with an event of those
who were predicted to be at an elevated risk) was 0.06
and 0.03 for the ‘At higher’ and ‘Higher than average’
predicted risk categories, respectively. In other words, of
those individuals who were estimated to have a >2.5% risk
of hospitalisation or death approximately 6% had an
event in 2015. (Regression coefficients and significance
levels of independent variables for multivariable logistic

regression models for each the six age and gender strata
are included in online supplementary appendix 3).
Discussion
We have developed a population-based model that identifies risk of hospitalisation for potentially preventable problems in a paediatric population including all children under
the age of 14 years living in the RER of Italy. The C-statistic
of 0.78 indicates that the model performs well. By comparison, in a study predicting high-cost paediatric patients,
Leininger et al reported a C-statistic of 0.73.9 In their work in
predictive risk modelling in the UK, Billings et al reported
a C-statistics of 0.68523 and C-statistics ranging from 0.731
to 0.780.24 However, neither of these papers focused on a
paediatric population. In a project also conducted in the
Emilia-Romagna region of Italy but focused on the adult
population, Louis et al11 reported a C-statistic of 0.856. Given
the similar organisation of the healthcare system and the
similar database used for the adult and paediatric analyses,

Table 3 Observed and predicted events by risk group
Risk groups
(predicted risk range)

Average
predicted risk, %

Observed
Expected frequency
Number of
prevalence, % based on predicted risk observed events

Lower than average (≤1.2%) 378 258
Higher than average
99 714
(>1.2%–2.5%)

0.5
1.7

0.5
1.8

2018
1690

1896
1758

At higher risk (>2.5%)
Total

5.4

5.5
1.2

2683
6391

2737
6391

N

49 486
527 458

Louis DZ, et al. BMJ Open 2018;8:e019454. doi:10.1136/bmjopen-2017-019454
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C-statistic (overall model)=0.78
Cut-off points for comparison
‘At higher risk’* ‘At higher risk’*+‘Higher
score
than average’† score
Sensitivity‡
Specificity§

0.43
0.91

0.70
0.72

PPV¶
True positives**

0.06
2737

0.03
4495

*‘At higher risk’ is defined as patients with a predicted risk of
hospitalisation of>2.5%.
†‘At higher risk’+‘Higher than average’, is defined as patients with
a predicted risk of hospitalisation of >1.2%.
‡Sensitivity is defined as the proportion of those hospitalised who
were predicted to be hospitalised (true positive rate).
§Specificity is the proportion of those not hospitalised who were
not predicted to be hospitalised (true negative rate).
¶PPV is the proportion of those predicted to be hospitalised who
were actually hospitalised.
**Positive predictives are the number of residents who were
predicted to be at risk of hospitalisation at the predicted risk
threshold and were actually hospitalised.
PPV, positive predictive value.

we believe that the somewhat lower C-statistic in the paediatric study results form the fact that hospitalisation is less
frequent in children.
We believe that the definition of the dependent variable used in our models increases the likelihood that
they are identifying patients whose risk may be reduced
through proactive care. We have updated previously
published criteria to include hospitalisations that may
have been prevented by currently available vaccines, and
we have used the logic of disease staging to include relevant hospitalisations that would have been missed using
solely primary ICD-9-CM codes. Specifics of the selection
criteria are available in the supplemental material.
The richness of the administrative data available in the
RER allowed for a robust definition of the predictive variables. The RER data allow for the linkage of patients’ use
of diverse inpatient and outpatient healthcare services
over multiple years. In addition, the ability to link child
and mother’s information allows the models to consider
some of the mother’s medical history such as the presence of chronic disease and use of prescription drugs in
the years prior to birth as well as complications that may
have arisen at birth.
There are limitations to our models. The models were
developed with administrative data that lack some of the
clinical specificity that would be useful in assessing patient
risk. Children who have not had the types of encounters
included in the RER database would have potentially
missing information. The RER database does not have
encounter level diagnostic data available documenting
visits with the primary care paediatrician. The administrative data have very limited information available about the
patient and family socioeconomic status. Our models use
8

prior utilisation among the predictor variables. With the
administrative date, we cannot distinguish appropriate
from inappropriate prior utilisation, which may bias our
results. Despite their limitations, administrative data have
many advantages for a project such as ours. They are relatively inexpensive to analyse and, in the case of the RER,
include a large population over multiple years.
While the evidence was mixed, a systematic review
suggests that hospitalisations can be prevented in children
with medical complexity.1 The Local Health Authority of
Parma has begun working with the primary care paediatricians caring for the patients identified by the models
to develop individual ‘profiles’ of children identified
as being at higher risk. Data in the profiles, along with
the more detailed information available in the medical
record, can be used by the paediatricians to assess what
additional intervention, if any, may help to manage the
child’s risk. For example, review of the profiles of higher
risk children can help identify children whose parents
might be contacted for a visit if they have not been seen
recently. Summaries of prescriptions that have been
filled from the profiles can be reviewed for potential over
use, under use or inappropriate use of mediation. Highrisk children with chronic illness might be referred to a
specialist or home healthcare provided.
The RER healthcare system offers several advantages
in the goal of reducing potentially preventable hospitalisation. Every child is enrolled with a primary care
paediatrician. The population is quite stable allowing for
continuity of care. Through the Italian NHS, every child
is entitled to healthcare with little or no cost at the point
of service. While the primary care paediatricians are paid
on a per-capita basis, the RER can negotiate incentive
payments and monitor improvements in care that may
help to reduce avoidable hospitalisations. If successful,
the results of the models can be applied by other Local
Health Authorities in the RER, other Italian regions and
other countries with similar data availability.
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